Food and Drug Administration

Food and Drug Administration. The agency is a federal science-based regulatory body within the United States Department of Health and Human Services, charged with protecting public health by ensuring the safety, efficacy, and security of a wide range of products. Its oversight extends to human and veterinary drugs, biological products, medical devices, the nation's food supply, cosmetics, and products that emit radiation. The agency's work, from pre-market review to post-market surveillance, is foundational to the American public health system and influences global regulatory standards.

History

The origins of the agency trace back to the Pure Food and Drug Act of 1906, a landmark piece of legislation spurred by public outrage documented in works like Upton Sinclair's The Jungle. This early law, championed by Harvey Washington Wiley, primarily focused on prohibiting adulterated and misbranded food and drugs. A significant expansion of authority came with the Federal Food, Drug, and Cosmetic Act of 1938, enacted following the Elixir Sulfanilamide tragedy, which mandated pre-market safety reviews for new drugs. Subsequent milestones include the Kefauver-Harris Amendments of 1962, which required proof of efficacy after the thalidomide crisis, and the establishment of the Prescription Drug User Fee Act in 1992 to accelerate drug review. The September 11 attacks led to further expansion of powers through laws like the Public Health Security and Bioterrorism Preparedness and Response Act.

Organization and structure

The agency is headed by the Commissioner of Food and Drugs, a position appointed by the President with consent from the Senate and currently held by Robert Califf. Its operations are divided into several major product-centric centers, including the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, and the Center for Devices and Radiological Health. Other key components are the Center for Food Safety and Applied Nutrition, the Center for Veterinary Medicine, and the Office of Regulatory Affairs, which conducts field inspections and enforcement activities. The agency maintains a network of laboratories and its headquarters are located in White Oak, Maryland.

Regulatory programs

Core regulatory activities involve a rigorous pre-market evaluation process for new medical products, such as the Investigational New Drug application and Premarket Approval for high-risk devices. For foods, programs focus on standards, labeling under the Nutrition Labeling and Education Act, and monitoring for contaminants. The agency enforces regulations against adulterated products, misleading advertising, and non-compliance through actions like warning letters, seizures, and injunctions. It also manages the MedWatch system for post-market safety surveillance and adverse event reporting, and oversees the Risk Evaluation and Mitigation Strategy for certain high-risk drugs.

Impact and controversies

The agency's decisions have profound impacts on medical innovation, public health, and the pharmaceutical industry, with approvals of therapies for conditions like HIV/AIDS and cancer being historic achievements. However, it has faced significant criticism and controversy, such as debates over the approval speed of drugs for Alzheimer's disease like Aduhelm, and handling of the opioid epidemic involving companies like Purdue Pharma. Other contentious issues include the regulation of electronic cigarettes, responses to the COVID-19 pandemic including Emergency Use Authorization for vaccines, and ongoing debates about its regulatory authority over dietary supplements following the Dietary Supplement Health and Education Act.

International cooperation

As a world leader in regulatory science, the agency engages extensively in global harmonization efforts to align standards and facilitate trade. It is a key member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and participates in initiatives like the Pharmaceutical Inspection Co-operation Scheme. The agency has mutual recognition agreements with counterparts such as the European Medicines Agency and works closely with the World Health Organization on issues ranging from vaccine prequalification to antimicrobial resistance. Its collaborations with agencies like Health Canada and the Therapeutic Goods Administration aim to strengthen global supply chain safety and regulatory convergence.

Category:Food and Drug Administration Category:United States Department of Health and Human Services agencies Category:1906 establishments in the United States